Further tests of the diagnostic usefulness of DDX11-AS1 confirmed that high DDX11-AS1 expression in the tumor specimens enabled the classification of HCC patients from normal specimens, suggesting that it is a viable diagnostic biomarker for HCC. The gene discussed is DDX11; the disease is hepatocellular carcinoma.